4-127633126-T-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_015693.4(INTU):c.92T>A(p.Phe31Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,614,092 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015693.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INTU | ENST00000335251.11 | c.92T>A | p.Phe31Tyr | missense_variant | 1/16 | 1 | NM_015693.4 | ENSP00000334003.5 | ||
INTU | ENST00000503952.5 | n.92T>A | non_coding_transcript_exon_variant | 1/17 | 1 | ENSP00000421995.1 | ||||
INTU | ENST00000504491.1 | c.89+9635T>A | intron_variant | 4 | ENSP00000422550.1 | |||||
INTU | ENST00000503626.5 | n.92T>A | non_coding_transcript_exon_variant | 1/18 | 2 | ENSP00000426287.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251424Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135880
GnomAD4 exome AF: 0.000112 AC: 164AN: 1461760Hom.: 2 Cov.: 31 AF XY: 0.000125 AC XY: 91AN XY: 727168
GnomAD4 genome AF: 0.000144 AC: 22AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74496
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.92T>A (p.F31Y) alteration is located in exon 1 (coding exon 1) of the INTU gene. This alteration results from a T to A substitution at nucleotide position 92, causing the phenylalanine (F) at amino acid position 31 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 08, 2024 | This sequence change replaces phenylalanine, which is neutral and non-polar, with tyrosine, which is neutral and polar, at codon 31 of the INTU protein (p.Phe31Tyr). This variant is present in population databases (rs148080788, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with INTU-related conditions. ClinVar contains an entry for this variant (Variation ID: 2079097). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The tyrosine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at